Amikacin

Amikacin is a semi-synthetic aminoglycoside antibiotic derived from kanamycin. It is effective against a wide range of gram-negative bacteria including multi-drug resistant strains. Mediocon Inc supplies pharmaceutical-grade Amikacin sulfate meeting USP, BP, and IP standards for injectable formulations.

Key Features

• Broad-spectrum aminoglycoside antibiotic
• USP/BP/IP compliant quality
• Effective against MDR gram-negative bacteria
• Suitable for injectable formulations

Applications

• Serious gram-negative bacterial infections
• MDR tuberculosis adjunct therapy
• IV/IM injectable formulations
• Hospital-acquired infection treatment

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings